Analysts' ratings for Health Catalyst HCAT over the last quarter vary from bullish to bearish, as provided by 6 analysts. The table below provides a concise overview of recent ratings by analysts, ...

BofA analyst Kevin Fischbeck upgraded UnitedHealth’s rating to ‘Buy’ from ‘Neutral’ and raised the price target to $450 from $420.

Throughout the last three months, 4 analysts have evaluated Globus Medical (NYSE:GMED), offering a diverse set of opinions from bullish to bearish. The following table summarizes their recent ratings, ...

Orthofix Medical (NASDAQ:OFIX) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below provides a snapshot of their recent ...

Across the recent three months, 10 analysts have shared their insights on CVS Health (NYSE:CVS), expressing a variety of opinions spanning from bullish to bearish. Summarizing their recent assessments ...

Two thousand years ago, physicians in Egypt documented their patients’ symptoms and treatments on papyrus scrolls. These early medical records served a simple, localized purpose: they supported direct ...

The Health Information Management field is constantly evolving. Industry changes are vast and vary from the implementation of electronic health records to an increased focus on protected health ...

AI is changing the way doctors diagnose health conditions and treat patients. There’s a lot of optimism about its potential for improving health outcomes. However, because AI requires massive amounts ...